Preventive Cardiology

Is HFpEF an Exercise Deficiency Syndrome?

HF and Exercise

The JACC published a four-part series last week in which experts spotlight exercise as a means of cardiovascular disease reduction, prevention, and treatment. The second paper in the series received a lot of attention, with one cardiologist speculating that it may be the best paper of the year.

The paper in question argues that a subgroup of patients with heart failure with preserved ejection fraction (HFpEF) have rarely exercised throughout their life. As a result, they have smaller hearts that do not adequately protect from heart failure during the aging process.  

It’s well established that consistent exercise results in increased cardiac mass, stroke volume, cardiac output, and peak oxygen consumption. But does physical inactivity lead to cardiac atrophy, reduced output, and reduced heart chamber size? The authors say yes. 

The paper cites nearly one hundred studies in support of its claim. Here are the highlights:

  • There is a strong association between physical activity, cardiorespiratory fitness, and heart function.
  • Aging results in a smaller, stiffer heart, but regular exercise mitigates these effects.
  • Physical inactivity leads to reduced output, smaller heart chamber size, and less ability to improve cardiac performance in the future with exercise.
  • A chronic lack of exercise is a major risk factor for HFpEF.

The Clinical Implications

Thinking of HFpEF as an exercise deficiency syndrome will help physicians better understand the condition, recognize risk earlier, and most importantly, provide a clear path to prevention. The authors recommend consistent exercise, especially before the age of 60, after which exercise intervention benefits are usually modest. 

The Takeaway

The fact that exercise is good for heart health may not be earth-shattering, but this literature review underscores the role of exercise as a major HFpEF risk factor. The authors propose that a subset of HFpEF patients have hearts that are smaller because they’ve been underexercised, making regular physical activity an effective prevention strategy.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Surgeries & Interventions June 23, 2025

Edwards’ Evoque Might Have More Adverse Events Than Previously Known June 23, 2025

Over a year after becoming the first FDA-approved transcatheter tricuspid valve replacement system, a new JACC study suggests Edwards Lifesciences’ Evoque TTVR system might have some risks that regulators hadn’t previously considered. Searching for more answers about Evoque’s real world risks, researchers pulled data from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database […]

Cardiology Business June 19, 2025

Lilly Buys Verve, Bringing Gene Editing Mainstream June 19, 2025

Gene editing for heart disease just got a major boost as Eli Lilly acquired Verve Therapeutics and its one-dose cholesterol drugs for up to $1.3B, marking a new path for Verve’s therapies to go mainstream. Part of the acquisition likely stems from Verve’s recent impressive trial results for its PCSK9-blocking treatment, VERVE-102, which lowered LDL-C […]

Cardiac Imaging June 19, 2025

New AI-driven Tool Aids in Mitral Valve Assessment June 19, 2025

By: Jimmy Su, Ph.D. Principal Scientist, Cardiovascular Ultrasound, Philips A new tool, Automated 3D Color Flow Quantification (3D Auto CFQ), removes the reliance on assumptions when quantifying mitral regurgitation and replaces it with a reliable and robust, AI-driven method that delivers precise measurement of mitral valve regurgitant volume (RVol) regardless of orifice shape and size. Eliminating assumptions: Quantification […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!